Emilio M. Treviño-Salinas, Andrés Murillo-Mendoza, A. Guzmán-López, Juan A SoriaLópez, Nancy M Dávila-Flores
{"title":"Synchronous Endometrial and Ovarian Cancer: Case Report","authors":"Emilio M. Treviño-Salinas, Andrés Murillo-Mendoza, A. Guzmán-López, Juan A SoriaLópez, Nancy M Dávila-Flores","doi":"10.51505/ijmshr.2021.5607","DOIUrl":null,"url":null,"abstract":"Asynchronous primary tumor of the endometrium and ovary is a rare and uncommon condition reported in 5% to 10% of endometrial or ovarian cancers. Endometrioid adenocarcinoma is the most common histology found in the cases. We report the case of a nulligesta with a synchronous endometrioid ovarian cancer and an endometroid adenocarcinoma of the endometrium. To know the difference between a synchronous cancer from a metastatic cancer is important to offer an optimal treatment and therefore a better prognosis to the patient. We present a case of a patient with this condition and a literature review.","PeriodicalId":285067,"journal":{"name":"International Journal of Medical Science and Health Research","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Science and Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51505/ijmshr.2021.5607","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Asynchronous primary tumor of the endometrium and ovary is a rare and uncommon condition reported in 5% to 10% of endometrial or ovarian cancers. Endometrioid adenocarcinoma is the most common histology found in the cases. We report the case of a nulligesta with a synchronous endometrioid ovarian cancer and an endometroid adenocarcinoma of the endometrium. To know the difference between a synchronous cancer from a metastatic cancer is important to offer an optimal treatment and therefore a better prognosis to the patient. We present a case of a patient with this condition and a literature review.